All updates
All updates
today 0中文产业新闻Chinese source评分6464 中文产业新闻精选Chinese source评分6666 艾力斯回应伏美替尼FURVENT三期失败：称化疗组评估差异大、专家认可疗效预期
中文产业新闻精选Chinese source评分8080 众生睿创RAY1225三期双周给药达主要终点，9mg组安慰剂校正减重20.46%
中文产业新闻精选Chinese source评分8080 行业研究｜罗氏 enicepatide 24mg 48 周减重与降糖数据对标替尔泊肽
中文产业新闻Chinese source评分3939 美国OMB启动86种基本药物的本土及近岸产能调研
中文产业新闻Chinese source评分7070 诺和诺德与 Nanexa 达成 11.65 亿欧元长效多肽递送合作，采用 PharmaShell 平台
中文产业新闻Chinese source评分7777 FDA批准旭化成Hovilpri（pritelivir）治疗耐药HSV感染
中文产业新闻Chinese source评分5454 罗氏Tecentriq获FDA批准用于III期dMMR结肠癌术后辅助治疗
中文产业新闻Chinese source评分4848 Life Biosciences ER-100 青光眼一期临床试验公布阶段性积极数据
中文产业新闻Chinese source评分5959 FDA连批两项肿瘤适应症，CDE同日征求GVHD与非临床PK意见
中文产业新闻Chinese source评分6363 MimiVax脑癌疫苗SurVaxMⅡb期SURVIVE试验未达OS主要终点，关键亚组显示生存获益
顶刊论文（社媒热度）精选评分8383 A fluctuation test for gastruloid heterogeneity.
顶刊论文（社媒热度）精选评分7272 Conversational diagnostic artificial intelligence in ambulatory primary care: a prospective feasibility study.
顶刊论文（社媒热度）评分5858 Quadrivalent human papillomavirus vaccination before pregnancy and pregnancy outcomes: nationwide, population based case-control study.
顶刊论文（社媒热度）评分6262 Extended follow-up of in vivo BCMA CAR-T therapy in relapsed/refractory multiple myeloma.
顶刊论文（社媒热度）精选评分8383 Alveolar stem cells transdifferentiate to drive bronchiolar regeneration.
顶刊论文（社媒热度）精选评分6868 Nutritional interventions' impacts on human milk: Three trials in low-resource settings.
顶刊论文（社媒热度）评分6464 Influenza A virus infection induces immune dysregulation in the placenta and fetus without vertical transmission in nonhuman primates.
顶刊论文（社媒热度）精选评分7979 Epigenetic aging and transposon dysregulation reflect size-related lifespan compression in dogs.
顶刊论文（社媒热度）精选评分7777 Insights into temporal and spatial dynamics of short association fiber formation in the human fetal brain.
中文产业新闻精选Chinese source评分8282 国产减重双雄亮剑：RAY1225三期减重22.24% vs BGM0504三期减重19.2%
文献与产业新闻评分2929 Ejiao (Asini Corii Colla) promotes thin endometrium repair via upregulation of the SDF-1/CXCR4 signalling axis in a mouse model
文献与产业新闻评分5252 Catching enhanced flexibility in antibody-antigen recognition: critical evaluation of physics-based and AI-driven methods
文献与产业新闻精选评分5151 Testing peripheral and central therapies for provoked vestibulodynia: results from the UPDATe trial
文献与产业新闻评分6060 Biomarker and Bioorthogonality Dual-Locked Chemiluminescent Probes for Cancer Urine Test
监管与产业动态评分2929 Lipoprotein(a)-dependent cardiovascular risk in different populations: are thresholds the same?
文献与产业新闻评分5656 Topological Engineering of NIR-II Emissive Conjugated Oligomers With Unexpected Excited-State Manifolds for Efficient Phototheranostics and Cancer Immunotherapy
文献与产业新闻评分5656 Modular Construction of Cyclic and Linear Quaternary Carbon Centers through Visible-Light-Induced Triplet Nitrene Transfer Reaction
监管与产业动态评分3030 Influence of perineal tears and body image disturbance on postpartum sexual quality of life: a cross-sectional study
中文产业新闻Chinese source评分2828 Genentech的RGT-419B（CDK2/CDK4抑制剂）启动HR+/HER2-乳腺癌Ib期临床试验
中文产业新闻Chinese source评分3535 Novartis启动NIO752针对额颞叶痴呆等原发性Tau蛋白病的II期篮式试验
中文产业新闻Chinese source评分3333 科伦博泰在中国启动芦康沙妥珠单抗（SKB264）联合SKB118治疗EGFR突变非鳞状NSCLC的Ⅱ期临床试验
中文产业新闻Chinese source评分2727 诺和诺德zenagamtide启动针对2型糖尿病、肥胖及超重人群的Ⅰ期临床试验
The Lancet Oncology精选评分5252 [Articles] Invasive interval breast cancer rates after digital breast tomosynthesis plus synthesised mammography versus digital mammography screening (TOSYMA): 24-month follow-up of the multicentre, open-label, randomised, controlled, superiority trial
The Lancet Oncology评分3030 [Comment] Time to say goodbye to full-field digital mammography in population-based screening?
STAT News评分5252 STAT+: Hospitals sue – again – to halt Trump administration’s 340B rebate pilot
STAT News评分4747 STAT+: Biotech leader, leading lab leak theorist no longer in consideration for top infectious disease role
中文产业新闻Chinese source评分3131 百年罗氏"慢人一拍"的合作智慧
中文产业新闻Chinese source评分6464 君赛生物 TIL 疗法 GC101 拟纳入 CDE 优先审评，治疗含 PD-1 抗体失败的转移性黑色素瘤
中文产业新闻Chinese source评分2727 吃着KRAS靶向药，肿瘤却"换了身份"——MIT揭示一种查不到耐药突变的耐药方式